pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Monoclonal Antibody · news · pharmadog
← back to Monoclonal Antibody
News · Monoclonal Antibody
785
stories
Aug 27, 26
Q&A: Akeso CEO spells out why she thinks its biliary tract cancer data are a big deal
endpoints
Aug 27, 26
Generate Bio drops as data accidentally leaked ahead of European conference
biospace
Aug 27, 26
AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis
biospace
Aug 27, 26
Osivax bags flu vaccine rights to pursue combination shot vision
fiercebiotech
Aug 27, 26
CAR Ts will only treat autoimmune diseases if we can scale delivery
biospace
Aug 27, 26
Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerate
biospace
Aug 26, 26
Spyre tumbles as immune drug misses mark in rheumatoid arthritis
biopharma dive
Aug 26, 26
Summit, Akeso tout biliary cancer win for PD-1/VEGF in China—but details are pending
biospace
Aug 26, 26
Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziihera
biospace
Aug 26, 26
Akeso, Summit hail ivonescimab's biliary tract cancer win in China-only Phase 3 trial
endpoints
Aug 26, 26
Spyre drops rheumatoid arthritis hopes for anti-TL1A drug after modest Phase 2 data
endpoints
Aug 26, 26
Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
fiercebiotech
Aug 26, 26
Spyre’s rheumatoid arthritis plan toppled by subpar TL1A data
fiercebiotech
Aug 25, 26
New Jazz cancer drug approval could drive blockbuster sales
biopharma dive
Aug 25, 26
J&J’s Imaavy wins label expansion; Two approvals in Japan
endpoints
Aug 25, 26
FDA approves Jazz's Ziihera in frontline gastric cancer
endpoints
Aug 24, 26
Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism
fiercebiotech
Aug 21, 26
Shareholder pressures Capricor; Lilly dives deeper into vaccines
biopharma dive
Aug 20, 26
Regeneron to challenge Ipsen as FDA clears bone disease drug
biopharma dive
Aug 20, 26
Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’
fiercebiotech
Aug 20, 26
Chutes & Ladders—Neumora shuffles leadership ahead of IND
fiercebiotech
Aug 20, 26
Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
biospace
Aug 20, 26
Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future
biospace
Aug 20, 26
Chai tees up Bristol Myers Squibb AI antibody discovery collab
fiercebiotech
Aug 20, 26
Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling
fiercebiotech
Aug 19, 26
FDA approves Regeneron’s garetosmab for disease that turns tissue to bone
endpoints
Aug 19, 26
Bristol Myers' partner Biokin says bispecific ADC clears fourth cancer trial in China
endpoints
Aug 19, 26
Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, more
biospace
Aug 18, 26
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
biospace
Aug 18, 26
Rebounding biotech funds expected to spur CDMO growth within year
biospace
← prev
page 15 of 27
next →